AWK Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Resilient Operations XGN Q1 2026 Earnings EPS Beat Highlights Cost Discipline Amid Revenue Uncertainty MRVI Q1 2026 Earnings EPS Surprises to the Upside Stock Falls Amid Cautious Outlook DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Costs Persist STVN Q1 2026 Earnings EPS Surpasses Estimates by Over 5 REZI Q1 2026 Earnings EPS Beats Estimates Despite Modest Stock Decline